Anzupgo
delgocitinib
Listed by LEO Pharma, Inc
- Strength
- 20 mg/g
- Form
- Cream
- Route
- Topical
- Class
- Janus Kinase Inhibitor
What it contains
- Delgocitinib 20 mg/g
FDA record
| Dosage form | Cream |
|---|---|
| Route | Topical |
| Drug class | Janus Kinase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 50222-280 |
| FDA application | NDA219155 |
| RxNorm concept | 2721167 |
| Package sizes listed | 3 |
| Marketed since | July 2025 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.